These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2424107

  • 1. Comparison of the effect of fluosol DA and dextran 40 on regional cerebral blood flow, infarction size, and mortality in cats with temporary occlusion of the middle cerebral artery.
    Kolluri S, Heros RC, Hedley-Whyte ET, Vonsattel JP, Miller D, Zervas NT.
    Surg Neurol; 1986 Jul; 26(1):3-8. PubMed ID: 2424107
    [Abstract] [Full Text] [Related]

  • 2. Effect of Fluosol on oxygen availability, regional cerebral blood flow, and infarct size in a model of temporary focal cerebral ischemia.
    Kolluri S, Heros RC, Hedley-Whyte ET, Vonsattel JP, Miller D, Zervas NT.
    Stroke; 1986 Jul; 17(5):976-80. PubMed ID: 3764970
    [Abstract] [Full Text] [Related]

  • 3. The effect of Fluosol-DA on oxygen availability in focal cerebral ischemia.
    Sutherland GR, Farrar JK, Peerless SJ.
    Stroke; 1984 Jul; 15(5):829-35. PubMed ID: 6433517
    [Abstract] [Full Text] [Related]

  • 4. Modification of cerebral ischemia with Fluosol.
    Peerless SJ, Nakamura R, Rodriguez-Salazar A, Hunter IG.
    Stroke; 1985 Jul; 16(1):38-43. PubMed ID: 3966263
    [Abstract] [Full Text] [Related]

  • 5. Protective effect of Fluosol-DA in acute cerebral ischemia.
    Peerless SJ, Ishikawa R, Hunter IG, Peerless MJ.
    Stroke; 1981 Jul; 12(5):558-63. PubMed ID: 6795765
    [Abstract] [Full Text] [Related]

  • 6. Effect of Fluosol-DA and hetastarch on local cerebral blood flow, cortical O2 availability and computerized EEG data during cerebral ischaemia.
    Tranmer BI, Iacobacci R, Feiler S.
    Neurol Res; 1990 Mar; 12(1):17-22. PubMed ID: 1692110
    [Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of artificial blood substitute (fluosol-DA 20%) in patients of cerebral ischemia].
    Oda Y, Murata T, Uchida Y, Mori K, Nagasawa S, Naruo Y, Asato R, Handa H.
    No Shinkei Geka; 1982 Jun; 10(6):637-44. PubMed ID: 7121730
    [Abstract] [Full Text] [Related]

  • 8. [Protective effect of fluosol-DA in acute cerebral ischemia (author's transl)].
    Ishikawa R, Peerless SJ, Hunter IG.
    No Shinkei Geka; 1981 Dec; 9(13):1503-8. PubMed ID: 6808409
    [Abstract] [Full Text] [Related]

  • 9. Effect of treatment with fluosol and mannitol during temporary middle cerebral artery occlusion in cats.
    Pereira BM, Weinstein PR, Rodriguez y Baena R.
    Neurosurgery; 1988 Aug; 23(2):139-42. PubMed ID: 3141828
    [Abstract] [Full Text] [Related]

  • 10. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%) on cerebral circulation in the monkey.
    Nagasawa S, Handa H, Naruo Y, Oda Y, Yonekawa Y, Takebe Y.
    Neurol Res; 1981 Aug; 3(3):237-50. PubMed ID: 6122175
    [Abstract] [Full Text] [Related]

  • 11. [Effect of perfluorochemicals on experimental cerebral ischemia].
    Yamashita K, Yamaguchi S, Kobayashi S.
    No To Shinkei; 1989 Dec; 41(12):1205-10. PubMed ID: 2627538
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of a blood substitute (Fluosol-DA, 20%) on cerebral ischemia.
    Oda Y, Handa H, Nagasawa S, Naruo Y, Asato R, Yonekawa Y.
    Neurol Res; 1982 Dec; 4(1-2):35-45. PubMed ID: 6127644
    [Abstract] [Full Text] [Related]

  • 13. Hyperoxic reperfusion is required to reduce infarct size after intravenous therapy with perfluorochemical (Fluosol-DA 20%) or its detergent component (poloxamer 188) in a poorly collateralized animal model. Absence of a role of polymorphonuclear leukocytes.
    Kolodgie FD, Farb A, Carlson GC, Wilson PS, Virmani R.
    J Am Coll Cardiol; 1994 Oct; 24(4):1098-108. PubMed ID: 7930204
    [Abstract] [Full Text] [Related]

  • 14. New treatment of cerebral vasospasm with Fluosol-DA 20%: protective effect on cerebral ischemia and change of cerebral blood flow (CBF).
    Handa H, Nagasawa S, Yonekawa Y, Naruo Y, Oda Y.
    Prog Clin Biol Res; 1983 Oct; 122():299-306. PubMed ID: 6878374
    [Abstract] [Full Text] [Related]

  • 15. [Studies on the effect of Fluosol DA (FC) against acute cerebral ischemia (author's transl)].
    Fujita K, Kusunoki T, Tamaki N, Matsumoto S.
    Neurol Med Chir (Tokyo); 1981 Dec; 21(12):1209-13. PubMed ID: 6173782
    [No Abstract] [Full Text] [Related]

  • 16. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation.
    Bajaj AK, Cobb MA, Virmani R, Gay JC, Light RT, Forman MB.
    Circulation; 1989 Mar; 79(3):645-56. PubMed ID: 2537160
    [Abstract] [Full Text] [Related]

  • 17. Effect of perfluorochemical (Fluosol-DA) on infarct morphology in dogs.
    Kolodgie FD, Dawson AK, Forman MB, Virmani R.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985 Mar; 50(2):119-34. PubMed ID: 2868560
    [Abstract] [Full Text] [Related]

  • 18. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%). Part II: Human cerebral blood flow.
    Nagasawa S, Handa H, Yonekawa Y, Oda Y, Tsuda Y, Yokoyama K.
    Neurol Res; 1983 Mar; 5(2):19-30. PubMed ID: 6140661
    [Abstract] [Full Text] [Related]

  • 19. Comparative studies with Fluosol, Dextran, their mixture, or autologous blood in experimental hypovolemic shock.
    Madjidi A, Beisbarth H, Frey R.
    Prog Clin Biol Res; 1983 Mar; 122():391-7. PubMed ID: 6192451
    [Abstract] [Full Text] [Related]

  • 20. Treatment of cerebral ischemia with Dextran-40 or Fluosol DA 20%.
    Kline RA, Negendank W, McCoy LE.
    Biomater Artif Cells Immobilization Biotechnol; 1992 Mar; 20(2-4):979-83. PubMed ID: 1382645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.